Virgo Health boosts consultancy team
February 25, 2011Medical Communications Caroline Gosling, Vantage, Virgo, Virgo Health PR, appointment, medical communications
Former Virgo Health PR managing director Caroline Gosling has moved to the company’s consultancy arm Vantage. She takes on a …
Sanofi picks two agencies for UK diabetes account
February 25, 2011Medical Communications Lantus, Sanofi-Aventis, Tudor Reilly, diabetes, medical communications account win, red health
Healthcare PR agencies Tudor Reilly and Red Health have jointly won the Sanofi-Aventis UK diabetes account after a five-way pitch. …
Cally Clarkson joins HealthEd
February 25, 2011Medical Communications Cally Clarkson, HealthEd, appointment, medical communications
Cheshire, UK-based medical education agency HealthEd has appointed Cally Clarkson as client services director. She has 10 years of healthcare …
Retaining pharma top talent
February 25, 2011Business Services MedImmune, careers, recruitment, talent retention
Strategies to co-ordinate talent retention differ between companies, and they may not always be as forward-focused as they could – …
Glioblastoma vaccine enters phase II
February 24, 2011Research and Development Cancer, GBM, ImmunoCellular Therapeutics, oncology
The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …
Digital Pharma: Sanofi shifts video focus to YouTube
February 24, 2011Medical Communications Digital Pharma blog, Sanofi-Aventis, online pharma video, youtube
Sanofi-Aventis has scaled back its online video ambitions and moved its web TV channel to YouTube. The move sees the …
Working Life: BMS UK’s market access director Patrick Hopkinson
February 24, 2011Business Services, Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, Patrick Hopkinson, Working Life, recruitment
Patrick Hopkinson, director of market access and external affairs at Bristol-Myers Squibb UK, talks to Pharmafocus about how he got …
Minesh Ghelani joins Astralis Group
February 24, 2011Business Services Astralis Group, Mishesh Ghelani, appointment, business services
Recruitment consultancy Astralis has appointed Minesh Ghelani as a senior consultant to its Life Sciences Practice.After obtaining his degree in …
Abbott wins $1.7bn Humira case
February 24, 2011Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis
Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …
50,000 NHS jobs to be cut
February 24, 2011False Economy, GPs, NHS, NHS reforms, TUC, nurses
NHS trusts are preparing to make a major series of job cuts as the health service wrestles with the need …
Red Door boosts management team
February 24, 2011Medical Communications Laura Clark, Liz Adams, Red Door Communications, appointment, medical communications
Red Door Communications has appointed its first `home grown’ consultant to its management team. Laura Clark has been made an …
Roche pulls out of vaccine alliance with Transgene
February 23, 2011Research and Development HPV, HPV vaccine, Roche, TG4001, Transgene, cervical cancer, cervical lesions, human papilloma virus, vaccines
Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …
Online international research register launched
February 23, 2011Research and Development CRD, Centre for Reviews and Dissemination, Department of Health, NIHR, National Institute for Health Research, Prospero, clinical research, health research register
The UK government has backed the creation of a free, international online register to improve the transparency of health research. …
No magic bullet, but a growing arsenal against lung cancer
February 23, 2011Research and Development ASA404, Cancer, Iressa, NSCLC, Tarceva, afatinib, crizotinib, figitumumab, lung cancer, non small cell lung cancer, non-small cell lung cancer
A man in his 70s is waiting for his appointment with the oncologist after being referred there by his family …
J&J hepatitis C drug begins phase III trials
February 23, 2011Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C
Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …
NICE yes for Votrient, no to Avastin
February 23, 2011Sales and Marketing Cancer, GSK, GlaxoSmithKline, Kidney cancer, NICE, Roche, avastin, bevacizumab, breast cancer
NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient on the same day it gave a final negative decision to Roche’s …
Commissioning Board to spearhead NHS reforms
February 23, 2011GP consortia, Health and Social Care Bill, NHS, NHS Commissioning Board, NHS reforms, PCT clusters, PCTs, SHAs, Sir David Nicholson, pathfinder consortia
NHS chief executive Sir David Nicholson says the new NHS Commissioning Board will be the driving force behind the health …
Kieran Murphy to head up life sciences for GE Healthcare
February 23, 2011Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing
GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …
Contract research news in brief
February 23, 2011Research and Development Bioanalytical Systems, Evotec, Iris Pharma, Kancera, Kinaxo Biotechnologies, NSF International, Pharmalytica Services, iNovacia
Acquisitions by Evotec, Kancera and NSF International head our latest CRO news round-up, along with updates from BASi and Iris …
Sanofi partners on dengue vaccine awareness
February 22, 2011Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines
Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
